Oxaliplatin resistance in pancreatic ductal adenocarcinoma is non‑significantly mediated by diminished drug uptake but is highly linked to a poor apoptotic response to the cytotoxic threat.

Oncol Rep · 2026 · PMC12670068 · PMID 41268611

Europe PMC DOI

hedged sentence

0.9400

closest p · 18.8× alpha

0.9400

boldest claim

The sentences

did not reach statistical significanceP>0.94not close (p > 0.1)

ATP7A (5.77±0.5-fold) and SLC22A3 (4.5±0.4-fold) were also enhanced but the differences did not reach statistical significance (P>0.94).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.